Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.

Many concepts of oral drug delivery are based on our comprehension of human gastrointestinal physiology. Unfortunately, we tend to oversimplify the complex interplay between the various physiological factors in the human gut and, in particular, the dynamics of these transit conditions to which oral dosage forms are exposed. Recent advances in spatial and temporal resolution of medical instrumentation as well as improved access to these technologies have facilitated clinical trials to characterize the dynamic processes within the human gastrointestinal tract. These studies have shown that highly relevant parameters such as fluid volumes, dosage form movement, and pH values in the lumen of the upper GI tract are very dynamic. As a result of these new insights into the human gastrointestinal environment, some common concepts and ideas of oral drug delivery are no longer valid and have to be reviewed in order to ensure efficacy and safety of oral drug therapy.

[1]  Werner Weitschies,et al.  An Automated System for Monitoring and Regulating the pH of Bicarbonate Buffers , 2013, AAPS PharmSciTech.

[2]  Martin Bergstrand,et al.  PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  W. Weitschies,et al.  Development of pressure-sensitive dosage forms with a core liquefying at body temperature. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  I. Wilding,et al.  The in vivo behaviour of enteric naproxen tablets coated with an aqueous dispersion of methacrylic acid copolymer , 1997 .

[5]  B. Meibohm,et al.  Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. , 2004, International journal of clinical pharmacology and therapeutics.

[6]  R. Havenaar,et al.  A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products , 1999, Applied Microbiology and Biotechnology.

[7]  I. Wilding,et al.  The effect of food on the in vivo behaviour of enteric coated starch capsules , 1994 .

[8]  A. Gasbarrini,et al.  Levothyroxine absorption in health and disease, and new therapeutic perspectives. , 2014, European review for medical and pharmacological sciences.

[9]  Ayman El-Kattan,et al.  Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. , 2007, Expert opinion on drug metabolism & toxicology.

[10]  K. Schulze Imaging and modelling of digestion in the stomach and the duodenum , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[11]  M. Horowitz,et al.  Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system. , 1983, Gut.

[12]  M. Wickham,et al.  Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model. , 2011, International journal of pharmaceutics.

[13]  E. Bjornsson,et al.  Nocturnal Antral pH Rises Are Related to Duodenal Phase III Retroperistalsis , 1997, Digestive Diseases and Sciences.

[14]  G. Boeckxstaens,et al.  The Acid Pocket: A Target for Treatment in Reflux Disease? , 2013, The American Journal of Gastroenterology.

[15]  J. H. Baron,et al.  Long-term recording and computer analysis of simultaneous gastric and duodenal pH under normal conditions in man , 1980 .

[16]  M. Karsdal,et al.  Influence of food intake on the bioavailability and efficacy of oral calcitonin. , 2009, British Journal of Clinical Pharmacology.

[17]  C. Lipinski Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[18]  M. Grimm,et al.  Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Characterization of the behavior of alginate-based microcapsules in vitro and in vivo. , 2009, International journal of clinical pharmacology and therapeutics.

[20]  A. Zinsmeister,et al.  Human gastric emptying and colonic filling of solids characterized by a new method. , 1989, The American journal of physiology.

[21]  M. Karsdal,et al.  Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin , 2008, BMC clinical pharmacology.

[22]  W. Weitschies,et al.  A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  P. Boesiger,et al.  Quantification of distal antral contractile motility in healthy human stomach with magnetic resonance imaging , 2006, Journal of magnetic resonance imaging : JMRI.

[24]  J. Proost,et al.  Sex Differences in the Pharmacokinetics of Antidepressants: Influence of Female Sex Hormones and Oral Contraceptives , 2014, Clinical Pharmacokinetics.

[25]  V. Bhargava,et al.  Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging , 2009, Alimentary pharmacology & therapeutics.

[26]  C. Christiansen,et al.  Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials , 2011, Journal of clinical pharmacology.

[27]  N. Hosten,et al.  Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging , 2005, Alimentary pharmacology & therapeutics.

[28]  Clive G. Wilson,et al.  In vivo imaging of drug delivery systems in the gastrointestinal tract. , 2011, International journal of pharmaceutics.

[29]  H. Lennernäs,et al.  Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women , 1997, Pharmaceutical Research.

[30]  Mark McAllister,et al.  Dynamic dissolution: a step closer to predictive dissolution testing? , 2010, Molecular pharmaceutics.

[31]  I. Wilding,et al.  The evaluation of an enteric-coated naproxen tablet formulation using gamma scintigraphy , 1993 .

[32]  Lutz Trahms,et al.  Impact of the intragastric location of extended release tablets on food interactions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[33]  C. I. Baastrup Roentgenological Studies of the Inner Surface of the Stomach and of the Movements of the Gastic Contents , 1924 .

[34]  C. Barthélémy,et al.  Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules , 1994, European Journal of Drug Metabolism and Pharmacokinetics.

[35]  D. Fleisher,et al.  Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration , 1999, Clinical pharmacokinetics.

[36]  L. Fändriks,et al.  Human duodenogastric reflux, retroperistalsis, and MMC. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[37]  Y F Shiau,et al.  Mechanisms maintaining a low-pH microclimate in the intestine. , 1985, The American journal of physiology.

[38]  M. Camilleri,et al.  Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine , 2008, The American Journal of Gastroenterology.

[39]  B. Bittner,et al.  Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens , 2015, Drug Research.

[40]  M. Ratain,et al.  Inconsistent Labeling of Food Effect for Oral Agents across Therapeutic Areas: Differences between Oncology and Non-Oncology Products , 2010, Clinical Cancer Research.

[41]  Jan Tack,et al.  The migrating motor complex: control mechanisms and its role in health and disease , 2012, Nature Reviews Gastroenterology &Hepatology.

[42]  C L Hoad,et al.  Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[43]  M. Türe,et al.  The Effect of Intravenous Pantoprazole and Ranitidine for Improving Preoperative Gastric Fluid Properties in Adults Undergoing Elective Surgery , 2003, Anesthesia and analgesia.

[44]  Clive G. Wilson,et al.  Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  Monitoring the Intragastric Distribution of a Colloidal Drug Carrier Model by Magnetic Resonance Imaging , 2001, Pharmaceutical Research.

[46]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[47]  A. Basit,et al.  Gut instincts: explorations in intestinal physiology and drug delivery. , 2008, International journal of pharmaceutics.

[48]  L. Trahms,et al.  Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules. , 1999, Die Pharmazie.

[49]  W. Weitschies,et al.  Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[50]  I. Wilding,et al.  In Vivo Evaluation of Enteric-Coated Naproxen Tablets Using Gamma Scintigraphy , 1992, Pharmaceutical Research.

[51]  Migrating motor complex cycle duration is determined by gastric or duodenal origin of phase III. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[52]  L. Marciani,et al.  Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[53]  Jeffrey W. Scott,et al.  Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects , 2016, Journal of clinical pharmacology.

[54]  W. Weitschies,et al.  Development of a pressure-sensitive glyceryl tristearate capsule filled with a drug-containing hydrogel. , 2014, International journal of pharmaceutics.

[55]  Martin C Garnett,et al.  Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. , 2014, Molecular pharmaceutics.

[56]  Christel A. S. Bergström,et al.  Is the full potential of the biopharmaceutics classification system reached? , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[57]  R. Singh,et al.  Disintegration of solid foods in human stomach. , 2008, Journal of food science.

[58]  R. Havenaar,et al.  Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. , 1997, Journal of dairy science.

[59]  J. Maltby,et al.  Fasting from midnight--the history behind the dogma. , 2006, Best practice & research. Clinical anaesthesiology.

[60]  J. Kühn,et al.  Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI. , 2014, Molecular pharmaceutics.

[61]  J. Malagelada,et al.  Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals , 1979, Digestive Diseases and Sciences.

[62]  R. Fisher,et al.  Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[63]  J Michael Newton,et al.  Gastric emptying of multi-particulate dosage forms. , 2010, International journal of pharmaceutics.

[64]  L. Fändriks,et al.  Surface area of the digestive tract – revisited , 2014, Scandinavian journal of gastroenterology.

[65]  Abdul W Basit,et al.  Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans. , 2015, Journal of pharmaceutical sciences.

[66]  Anette Müllertz,et al.  In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[67]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[68]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[69]  John J Totman,et al.  Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. , 2010, Gastroenterology.

[70]  Christos Reppas,et al.  In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[71]  J. Madsen,et al.  Human migrating myoelectric complex in relation to gastrointestinal transit of a meal. , 1990, Gut.

[72]  A. Shafik,et al.  Physiological assessment of the function of the ileocecal junction with evidence of ileocecal junction reflexes. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[73]  H. Mönnikes,et al.  Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[74]  Sang Chung,et al.  New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process , 2008, Journal of clinical pharmacology.

[75]  M. Yasin,et al.  An Investigation into the Utility of a Multi-compartmental, Dynamic, System of the Upper Gastrointestinal Tract to Support Formulation Development and Establish Bioequivalence of Poorly Soluble Drugs , 2012, The AAPS Journal.

[76]  Sebastian Polak,et al.  Population-Based Mechanistic Prediction of Oral Drug Absorption , 2009, The AAPS Journal.

[77]  Bertil Abrahamsson,et al.  Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[78]  P. Boesiger,et al.  The effect of macronutrients on gastric volume responses and gastric emptying in humans: A magnetic resonance imaging study. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[79]  J. Malagelada Quantificantion of gastric solid-liquid discrimination during digestion of ordinary meals. , 1977, Gastroenterology.

[80]  W. Weitschies Oral Anticancer Drugs: Back to Square One , 2013, Clinical pharmacology and therapeutics.

[81]  M. Grimm,et al.  Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System. , 2015, Journal of pharmaceutical sciences.

[82]  J. P. Ebel,et al.  An in Vitro/in Vivo Correlation for the Disintegration and Onset of Drug Release from Enteric-Coated Pellets , 1993, Pharmaceutical Research.

[83]  P. Boesiger,et al.  The effect of gastric secretion on gastric physiology and emptying in the fasted and fed state assessed by magnetic resonance imaging , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[84]  Frédéric Carrière,et al.  Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs. , 2016, Biochimie.

[85]  E. Brendel,et al.  Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[86]  M. Camilleri Integrated upper gastrointestinal response to food intake. , 2006, Gastroenterology.

[87]  R. Spiller,et al.  Emptying of the terminal ileum in intact humans: Influence of meal residue and ileal motility , 1987 .

[88]  L. Trahms,et al.  Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[89]  J. H. Baron,et al.  Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine. , 1984, Gut.

[90]  Lutz Trahms,et al.  Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.

[91]  I. Wilding,et al.  Correlation of the Gastric Emptying of Nondisintegrating Tablets with Gastrointestinal Motility , 1991, Pharmaceutical Research.

[92]  F. Podczeck,et al.  The influence of non‐disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers , 2007, The Journal of pharmacy and pharmacology.

[93]  W. Weitschies,et al.  A biorelevant dissolution stress test device – background and experiences , 2010, Expert opinion on drug delivery.

[94]  Mark McAllister,et al.  Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[95]  G. Dresser,et al.  Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice , 2003, Clinical pharmacology and therapeutics.

[96]  W. Weitschies,et al.  Simulating the postprandial stomach: physiological considerations for dissolution and release testing. , 2013, Molecular pharmaceutics.

[97]  G. Jefferson The Human Stomach and the Canalis Gastricus (Lewis). , 1915, Journal of anatomy and physiology.

[98]  C. Dooley,et al.  Variability of migrating motor complex in humans , 1992, Digestive Diseases and Sciences.

[99]  J. Seenan,et al.  Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic , 2008, Gut.

[100]  I. Wilding,et al.  Enteric coated HPMC capsules designed to achieve intestinal targeting. , 2002, International journal of pharmaceutics.

[101]  A. Basit,et al.  Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers , 2005 .

[102]  J. Tack,et al.  Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium. , 2016, Journal of pharmaceutical sciences.

[103]  M. Karlsson,et al.  Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions , 2016, Pharmaceutical Research.

[104]  Gordon L Amidon,et al.  Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. , 2009, Molecular pharmaceutics.

[105]  Susan A. Barker,et al.  Achieving Antral Grinding Forces in Biorelevant In Vitro Models: Comparing the USP Dissolution Apparatus II and the Dynamic Gastric Model with Human In Vivo Data , 2011, AAPS PharmSciTech.

[106]  M. Alpsten,et al.  Absorption of acetylsalicylic acid from enteric‐coated tablets in relation to gastric emptying and in‐vivo disintegration , 1984, The Journal of pharmacy and pharmacology.

[107]  W. Weitschies,et al.  Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution. , 2013, Molecular pharmaceutics.

[108]  Mark Feldman,et al.  Fasting gastric pH and its relationship to true hypochlorhydria in humans , 1991, Digestive Diseases and Sciences.

[109]  Clive G. Wilson,et al.  Gastrointestinal Transit and Drug Absorption , 2005 .

[110]  G. Boeckxstaens,et al.  The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD , 2009, Gut.

[111]  A. Basit,et al.  Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption. , 2010, International journal of pharmaceutics.

[112]  Werner Weitschies,et al.  Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.